Studied for synergistic GHRH/GHS receptor co-activation and amplified pulsatile growth hormone release patterns
Some uncommon side effects that could occur are some weakness, nausea, bowel problems, dizziness, lethargy, weight loss, thirst, nervous irritability, itchy skin, frequent urination, high levels of calcium
*Individual experiences vary
$124.99 In stock Research goals: Recovery & Healing Description BPC-157 + TB-500 Blend combines two synthetic peptides commonly studied in tissue-repair and recovery research: BPC-157 (Body Protection Compound-157), a stable gastric pentadecapeptide derived from a human gastric juice fragment, and TB-500 (Ac-LKKTETQ), the N-acetylated 1723 fragment of thymosin beta-4
Published studies have reported plasma GHK-Cu levels of approximately 200 ng/mL at age 20, declining to approximately 80 ng/mL by age 60
This is given through an intramuscular injection